MGC Pharmaceuticals has signed a deal to distribute cannabis-based pharmaceutical products throughout Europe and to produce and cultivate medical cannabis in Malta.
The Australian company made the distribution agreement with AM Mangion, a Maltese company specialising in the distribution of products in the medical sector.
MGC will supply an “initial range” of products which AM Mangion will distribute through Malta, Italy, France, Spain, Portugal and the UK – and also in the Middle East and North Africa.
Other products will be included for distribution on an agreed ad hoc basis, MGC said.
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
LATEST ALERTS
